| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Sr VP &Chief Commercial Offic | President, Pharma Pckg Systems
4 companies
Flynn Karen serves as a Director at QTRX and has filed Form 4s across 4 companies. Across recent SEC filings that breaks down to 0 buys and 6 sells. Those positions are worth an estimated $9.3M at current prices.
The biggest single holding is WST (~$8.3M) as Sr VP &Chief Commercial Offic. The recent filings there lean toward selling, a net 58,059 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | STVN Stevanato Group S.p.a. | Director | Sell | 1,493 | $17.09 | $25,515.37 | -20.6% | |
| Aug 7, 2018 | WST West Pharmaceutical Services Inc | Sr VP &Chief Commercial Offic | Sale+OE | 20,458 | $116.23 | $2,377,833.34 | -48.7% | |
| Sep 6, 2016 | WST West Pharmaceutical Services Inc | Sr VP &Chief Commercial Offic | Sell | 14,581 | $83.28 | $1,214,305.68 | -51.9% | |
| Nov 10, 2015 | WST West Pharmaceutical Services Inc | President, Pharma Pckg Systems | Sale+OE | 18,020 | $63.03 | $1,135,723.11 | -42.3% | |
| May 22, 2015 | WST West Pharmaceutical Services Inc | President, Pharma Pckg Systems | Sale+OE | 3,091 | $55.24 | $170,736.64 | -11.2% | |
| May 18, 2015 | WST West Pharmaceutical Services Inc | President, Pharma Pckg Systems | Sale+OE | 1,909 | $55.00 | $104,995.00 | -7.2% |